These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15756728)

  • 1. [Increased carcinoembryonic antigen level: which diagnosis?].
    Gärtner H; Maier KP
    Dtsch Med Wochenschr; 2005 Feb; 130(7):353. PubMed ID: 15756728
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinico-diagnostic significance of tumor markers in malignant neoplasms].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar' BN
    Voen Med Zh; 1993 Mar; (3):27-8. PubMed ID: 8498043
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of tumour markers in cancer diagnosis and treatment.
    Higgins C
    Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can cancer be diagnosed with a blood test during routine examinations?
    Weiss PA; Weiss PA
    Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased level of carcinoembryonal antigen is not primarily a marker for ovarian cancer].
    Kristensen CA; Roed HM
    Ugeskr Laeger; 2005 Jan; 167(2):189; author reply 190. PubMed ID: 15697136
    [No Abstract]   [Full Text] [Related]  

  • 7. [CME--laboratory 4. "Tumor marker"].
    von Eckardstein A
    Praxis (Bern 1994); 2007 Nov; 96(45):1781-2. PubMed ID: 18050604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Criteria for using tumor markers. 2: Indications and interpretation].
    Fateh-Moghadam VA; Stieber P
    Fortschr Med; 1996 Mar; 114(7):38-40. PubMed ID: 8900968
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
    Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
    J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen].
    Averbach M
    Arq Gastroenterol; 1997; 34(1):1-2. PubMed ID: 9458952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lack of prognostic significance of carcinoembryonic antigen (CEA) preoperative serum levels in patients with advanced larynx cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Przegl Lek; 2006; 63(2):68-71. PubMed ID: 16969905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen monitoring for early detection of asymptomatic incurable metastatic colorectal cancer.
    Rother M
    J Clin Oncol; 2007 Apr; 25(10):1293-4; author reply 1294. PubMed ID: 17401025
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANDA cyst-fluid analysis: eats, shoots and leaves?
    Anderson MA; Kwon RS; Scheiman JM
    Gastrointest Endosc; 2009 May; 69(6):1103-5. PubMed ID: 19410042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in lung cancer].
    Gómez de Terreros Caro FJ; Alvarez-Sala Walther R; Prados Sánchez C; Díaz Ajero P
    An Med Interna; 2001 May; 18(5):289. PubMed ID: 11496575
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increased carcinoembryonic antigen: what is the diagnosis?].
    Gärtner H; Maier KP
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():95. PubMed ID: 16379259
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of tumor markers in breast cancer management.
    Lenahan C; Garibyan L; Pories S
    Curr Surg; 2004; 61(6):532-7. PubMed ID: 15590016
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.